Thulium laser and growth factors for hair loss
Part of Skin clinical trials.
This trial tests whether a special laser combined with growth factor injections can help regrow hair in people with common hereditary hair loss (androgenetic alopecia). It aims to find a new treatment option that may work better than current methods.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with hereditary hair loss (androgenetic alopecia)
- You are in overall good health without serious medical conditions
- You are not pregnant or breastfeeding
- You are willing to come in for all study visits
- You have not used certain medications (like isotretinoin) or had recent laser treatments on your scalp
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether combining platelet-rich plasma (PRP) injections with botulinum toxin type A (Botox) can help regrow hair in people with male or female pattern baldness. It aims to see if this combination is safe and effective for treating androgenetic alopecia.
This trial tests whether a lotion containing a beneficial bacteria (Lactobacillus reuteri) can help with male or female pattern hair loss. The treatment is applied directly to the scalp.
This trial tests an investigational drug called OLX72021 for male pattern hair loss (androgenetic alopecia). It aims to see if the drug is safe and effective in healthy men with mild to moderate hair loss.
This trial tests a new treatment using exosomes (tiny particles that help cells communicate) for male pattern baldness. It may help regrow hair or slow further loss.
This study compares a new peptide-based hair serum with minoxidil (a common hair-regrowth treatment) in people with androgenetic alopecia, a type of hair loss caused by genetics and hormones. The trial lasts 24 weeks and measures how well each treatment works.
This trial tests if a non-ablative laser can help treat scarring alopecia (a type of hair loss where follicles are replaced by scar tissue). Researchers will also study your hair follicles' genes to understand how the laser works. It may be an option if your hair loss has been stable for at least 3 months.
Hear when a new Androgenetic Alopecia (AGA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.